Satsuma Pharmaceuticals, Inc. (STSA) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist THL Equity Advisors VI, LLC mit 854,575,000 Aktien. Weitere bedeutende Anteilseigner sind Thomas H. Lee Equity Fund VI, L.P. und TAKANASHI KEN.
STSA Insider-Beteiligungen
Größter Aktionär
THL Equity Advisors VI, LLC
854,575,000 Aktien
Käufe (12 Monate)
0
$0.00 Wert
Verkäufe (12 Monate)
0
$0.00 Wert
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Thl Equity Advisors Vi, Llc |
10 Percent Owner |
854,575,000 |
2010-11-24 |
|
| 2 |
Thomas H. Lee Equity Fund Vi, L.p. |
10 Percent Owner |
470,908,524 |
2010-11-24 |
|
| 3 |
Takanashi Ken |
10 Percent Owner |
24,847,694 |
2023-06-08 |
|
| 4 |
Shin Nippon Biomedical Laboratories, Ltd. |
10 Percent Owner |
22,053,581 |
2023-06-08 |
|
| 5 |
Kollins John A |
President and CEO |
505,000 |
2022-06-07 |
|
| 6 |
Commodore Capital Lp |
Director |
461,286 |
2022-11-16 |
|
| 7 |
O'neil Thomas P. |
Chief Financial Officer |
190,000 |
2022-06-07 |
|
| 8 |
Albrecht Detlef |
Chief Medical Officer |
190,000 |
2022-06-07 |
|
| 9 |
Leonard Braden Michael |
Director |
150,000 |
2022-11-23 |
|
| 10 |
Stanley Heidi B |
CEO/chair of Sterling Savings |
70,212 |
2009-10-15 |
|
| 11 |
King Thomas Braxton |
Director |
30,000 |
2022-06-07 |
|
| 12 |
Sandoval Elisabeth |
Director |
30,000 |
2022-06-07 |
|
| 13 |
Shah Rajeev M. |
Director |
30,000 |
2022-06-07 |
|
| 14 |
Riebe Michael T |
Director |
30,000 |
2022-06-07 |
|
| 15 |
Soloway Thomas P |
Director |
30,000 |
2022-06-07 |
|
| 16 |
Harsch Mutya |
Director |
30,000 |
2022-06-07 |
|
| 17 |
Ra Capital Management, L.p. |
10 Percent Owner |
30,000 |
2022-06-07 |
|
| 18 |
Lukatch Heath |
Director |
30,000 |
2022-06-07 |
|
| 19 |
Seibly John Gregory |
CEO/president - Sfc |
15,784 |
2014-04-08 |
|
| 20 |
Eckhardt Ezra |
COO - Sterling Financial Corp. |
9,771 |
2014-04-08 |
|
Keine Beteiligungsdaten für STSA verfügbar.
